Skip to main content
Veterinary Medicines

NEOTYL, unguent intramamar

Authorised
  • NEOMYCIN SULFATE
  • Prednisolone
  • Retinol palmitate
  • Tylosin tartrate

Product identification

Medicine name:
NEOTYL, unguent intramamar
Active substance:
  • NEOMYCIN SULFATE
  • Prednisolone
  • Retinol palmitate
  • Tylosin tartrate
Target species:
  • Cattle (cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Prednisolone
    10.00
    milligram(s)
    /
    1.00
    Syringe
  • Retinol palmitate
    10000.00
    international unit(s)
    /
    1.00
    Syringe
  • Tylosin tartrate
    250.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Meat and offal
        7
        day
      • Milk
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Pasteur Filiala Filipesti S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pasteur Filiala Filipesti S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 150398
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 20/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."